We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATLC icon
2951
Atlanticus Holdings
ATLC
$1.52B
$220K ﹤0.01%
7,437
+397
+6% +$13.1K
PLBC icon
2952
Plumas Bancorp
PLBC
$429M
$219K ﹤0.01%
5,957
+217
+4% +$7.88K
CWBC
2953
Community West Bancshares
CWBC
$684M
$219K ﹤0.01%
10,987
+509
+5% +$9.8K
OLPX
2954
DELISTED
Olaplex Holdings
OLPX
$218K ﹤0.01%
113,744
-20,559
-15% -$42.9K
TBRG
2955
DELISTED
TruBridge
TBRG
$218K ﹤0.01%
23,613
-1,207
-5% -$11.7K
KPTI icon
2956
Karyopharm Therapeutics
KPTI
$48M
$217K ﹤0.01%
9,602
+395
+4% +$6.93K
SSBK
2957
DELISTED
Southern States Bancshares
SSBK
$217K ﹤0.01%
8,372
+288
+4% +$7.52K
III icon
2958
Information Services Group
III
$251M
$217K ﹤0.01%
53,659
+40
+0.1% +$173
EWI icon
2959
iShares MSCI Italy ETF
EWI
$1.08B
$216K ﹤0.01%
5,730
-540
-9% -$18.9K
VRA icon
2960
Vera Bradley
VRA
$98.7M
$216K ﹤0.01%
31,771
+1,171
+4% +$8.59K
BCAB icon
2961
BioAtla
BCAB
$5.74M
$216K ﹤0.01%
1,256
+42
+3% +$5.22K
ONIT
2962
Onity Group
ONIT
$332M
$213K ﹤0.01%
7,904
+292
+4% +$8.08K
DSGN icon
2963
Design Therapeutics
DSGN
$876M
$211K ﹤0.01%
52,452
+1,588
+3% +$4.24K
SSTI icon
2964
SoundThinking
SSTI
$103M
$211K ﹤0.01%
13,257
-40
-0.3% -$763
ASND icon
2965
Ascendis Pharma A/S
ASND
$16.8B
$210K ﹤0.01%
1,390
+100
+8% +$14.3K
PLSE icon
2966
Pulse Biosciences
PLSE
$3.02B
$210K ﹤0.01%
24,121
+724
+3% +$6.66K
ALDX icon
2967
Aldeyra Therapeutics
ALDX
$93.5M
$210K ﹤0.01%
64,074
+2,211
+4% +$7.27K
INOD icon
2968
Innodata
INOD
$2.04B
$209K ﹤0.01%
31,659
+1,405
+5% +$11.7K
HFFG icon
2969
HF Foods Group
HFFG
$83.4M
$208K ﹤0.01%
59,447
+1,826
+3% +$7.99K
SAMG icon
2970
Silvercrest Asset Management
SAMG
$79.9M
$208K ﹤0.01%
13,158
+359
+3% +$5.89K
TSE
2971
DELISTED
Trinseo
TSE
$207K ﹤0.01%
54,873
-7
-0% -$37
WPP icon
2972
WPP
WPP
$5.94B
$207K ﹤0.01%
4,364
+368
+9% +$17.3K
NJ
2973
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$206K ﹤0.01%
20,058
+2,028
+11% +$20.8K
ENIC icon
2974
Enel Chile
ENIC
$6.28B
$205K ﹤0.01%
67,330
+160
+0.2% +$469
BH icon
2975
Biglari Holdings Class B
BH
$1.21B
$205K ﹤0.01%
1,082
-78
-7% -$13.2K

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.